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are Disparities
oving From Gray to Black and White*
ohn S. Rumsfeld, MD, PHD, FACC,†
ric D. Peterson, MD, MPH, FACC‡
enver, Colorado; and Durham, North Carolina
quity in the delivery of health care is one of the principal
omains of health care quality as defined by the Institute of
edicine (IOM) (1). Despite this, more than 100 studies
ave demonstrated racial differences in cardiovascular care
n the U.S. These pervasive findings have prompted the
OM, the Agency for Healthcare Research and Quality
AHRQ), and the major cardiovascular societies to launch
ational campaigns designed to increase awareness of racial
isparities in care as well as to stimulate efforts to overcome
are inequities (2,3).
See page 72
In this issue of the Journal, Groeneveld et al. (4) add to
ur understanding of racial differences in cardiovascular care
hrough their investigation of the use of implantable cardiac
efibrillators (ICDs). Studying a national sample, the in-
estigators found that African American patients hospital-
zed with ventricular tachycardia, ventricular fibrillation, or
ardiac arrest were only about half as likely as Caucasians to
eceive an ICD. Examining these differences over a 10-year
eriod, however, the investigators noted a significant nar-
owing of the “racial gap” in ICD use, due in part to regional
iffusion of the technology. More specifically, areas of the
ountry with a higher proportion of African Americans
e.g., the South) tended to be slower at adopting ICD use
mong sudden cardiac death survivors. Over time, however,
here was some “geographic equalization” of ICD availabil-
ty, resulting in greater use of the technology among African
mericans. In particular, expanded use of ICDs at non-
cademic hospitals was associated with a narrowing of racial
ifferences at these types of hospitals. Despite this, African
mericans remained 30% less likely than Caucasians to
eceive an ICD at the end of the study period.
This study, or more generally, any report of care disparity,
hould trigger three questions in readers’ minds. First, are
he observed differences in care real (i.e., not due to
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Denver Veterans Affairs Medical Center/University of Colorado Health
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iews expressed in this article are those of the authors and do not necessarily represent
he views of the Department of Veterans Affairs.onfounding clinical factors)? Second, are these differences
mportant (i.e., do they measurably affect patients’ health
nd well being)? And third, if the disparities are real and
mportant, what can be done to minimize or eliminate
hem?
The short answer to whether racial disparities exist in
CD implantation is “probably.” Certainly, the study by
roeneveld et al. (4) demonstrates that the rate of ICD
mplantation differs between African Americans and Cau-
asians. However, the study, based on administrative claims
ata, lacks potentially important clinical details that could
ontribute to observed treatment patterns. Without such
ata, it remains possible to challenge the notion that lower
se in African Americans constitutes “underuse.” For exam-
le, African-American patients were more likely to have
lectrolyte disturbances, a potentially reversible cause of
entricular dysrhythmias not mandating ICD implantation.
frican Americans were also more likely to suffer anoxic
rain injury with cardiac arrest, and it is possible that ICD
mplantation was not deemed appropriate for patients with
ignificant impairment. Although these possibilities exist, it
s difficult to imagine that they fully explain the marked
acial variability in implantation found in this study.
The next question is whether the observed differences in
CD implantation affect patient outcomes. Unfortunately,
he current study did not include downstream patient event
r survival rates. However, there is strong evidence from
andomized trials that patients surviving sudden cardiac
eath live significantly longer with ICD implantation com-
ared with patients without ICDs (5). Given the high risk
f the study population, it is certainly possible that racial
isparities in implantation could translate into higher mor-
ality for African Americans.
Under the reasonable assumption that racial disparities in
CD implantation exist and can affect patient outcomes, the
ey issue becomes how to eliminate these differences. The
tudy by Groeneveld et al. (4) provides one interesting
ead—the diffusion of technology. By highlighting signifi-
ant geographic and institutional variation in the diffusion
f ICD devices into routine clinical practice, this study
uggests that reducing this variation may reduce racial
isparity.
In this regard, it is helpful to place the issue of racial
isparity in cardiac care within a more general model of the
doption of evidence-based care in clinical practice (6).
doption of new treatment should ideally be initiated after
ell-executed clinical trials and observational studies define
hich patient populations benefit from the therapy. These
ndings should then be rapidly summarized into clear
ractice guideline recommendations. Finally, quality assess-
ent and performance improvement initiatives should be
tilized to promote broad-based adoption of these new
ecommendations in general clinical practice. Because this
pproach emphasizes the standardization of care where
vidence supports that a given therapy be provided to all
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acial disparities.
Although this model is well supported in theory, real
edicine presents multiple challenges to its application.
trong evidence may not be available to guide a given
reatment decision. Even when clinical trials have been
one, key patient subgroups (co-morbid illness, advanced
ge, women, minorities) may be underrepresented (7).
hus, clinicians often are placed in a gray zone in which
edical decisions are made without clinical certainty. These
ray areas of medicine allow more subjective factors to enter
he decision-making process and have the potential to lead
o racial disparity.
Patients also face uncertainty when asked to consider
edical treatments. In the case of ICD implantation, it
akes a great deal of trust in one’s caregivers and in
echnologic science in general to permit implantation of a
shock-box” into one’s chest. This may be coupled with
oncern about the potential economic implications of im-
lantation. The clinician-patient relationship therefore as-
umes a critical role. Clinicians should clearly convey to
atients the potential risks, benefits, and alternative treat-
ent options in a manner that will stimulate informed
ecision-making. However, surveys have found that racial
inorities are more likely to report poor communication
ith their physicians, which may contribute to a reluctance
o undergo cardiac procedures compared with Caucasian
atients (8–10).
Finally, we have inadequate systems of care to support
apid and complete implementation in clinical practice even
hen the evidence is compelling (1). In the study by
roeneveld et al. (4), only about 10% of the overall sudden
ardiac death survivors received an ICD, even after a decade
r more of strong and expanding randomized trials. Thus,
he “equality issue” is dwarfed by a more general failure to
dopt evidence-based care in all patients.
To advance the model of adoption of evidence-based care
s a means of reducing racial disparities, several things
hould be done:
Reduce the “grayness” of medicine through better evidence: As
evidence for the effectiveness of a given therapy mounts,
care decisions become more clear-cut. In such “black and
white” situations, the impact of patient’s skin color should
be minimized. Ongoing support of both clinical research
(emphasizing studies with more representative patient
populations and ensuring the inclusion of minorities) and
health services/outcomes research (emphasizing studies of
the best methods to implement evidence-based care in
practice) by government agencies and foundations are
essential.
Promote a better patient-clinician interface: Patient activa-
tion, whereby patients are empowered through education
initiatives to have a better understanding of their disease
and the treatments available to modify its course, can help
patients be more proactive about the care they receive m(11). Cultural sensitivity and communication training for
health professionals may promote a better environment in
which the need for invasive procedures such as ICD
placement can be discussed (8).
Provide up-to-date and explicit clinical guidelines: Because
guidelines have, in many ways, replaced textbooks as the
primary source of clinical reference, and because quality
indicators and performance measures are derived from
guidelines, it is essential that they stay up to date. The
American College of Cardiology (ACC) and other major
cardiovascular professional societies, as well as appropriate
governmental and regulatory agencies, should maintain a
commitment to the ongoing development, frequent up-
dating, and dissemination of evidence-based guidelines.
Promote quality improvement programs: Quality improve-
ment programs should specifically promote the imple-
mentation of guideline-based care for all eligible patients,
and thereby should help reduce inappropriate variation in
care including racial disparities. Multidisciplinary collab-
orative care programs are most likely to promote highest
quality of care, and advances in information technology
(e.g., electronic medical record, clinical reminders,
e-health solutions) are likely to bolster these efforts (12).
National quality improvement programs, such as the
ACC-National Cardiovascular Data Registry, can provide
clinicians with comprehensive feedback on their care
practices, benchmarked with their peers (13). Although
controversial, programs that link payment incentives to
quality initiatives (so called pay-for-quality programs)
may serve to intensify interest in meeting quality-of-care
standards.
Finally, ensure that performance measurement considers
equity: National efforts to measure and improve care
should provide clinicians with feedback on care stratified
by age, gender, race, and other historically underserved
populations. As in public education, we may need a “no
patient left behind” policy for evidence-based care.
By definition, the provision of high-quality care includes
he delivery of equitable care. The study by Groeneveld et al.
4) helps us take a step forward in our understanding of
acial disparities, not just by highlighting a gap in care between
frican American and Caucasian patients, but by calling
ttention to a potential avenue for resolution through improved
iffusion of technology. Promoting the adoption of evidence-
ased care in practice, the cornerstone of quality improvement,
ay be the best avenue to reduce variation in the diffusion of
echnology. It is hoped that better evidence, timely guidelines,
nd both local and national quality initiatives will provide the
light” necessary to remove the grayness of medicine that has
upported racial disparities to this point.
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enver VA Medical Center, Cardiology (111B), 1055 Clermont
treet, Denver, Colorado 80220-3808. E-mail: John.Rumsfeld@
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